Neuropace Inc (NPCE) Annual Balance Sheets

Annual · GAAP · USD millions
Access NPCE quarterly Balance Sheets →
The balance sheet figures below highlight longer-term patterns in how Neuropace Inc finances operations and invests in assets.
Annual Report, GAAP in USD millions
ITEM
(Dec 31 2025)
(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Assets
Cash & cash equivalent21.69
Short-term Investments, Total39.37
Cash & Short-term Investments60.00
Accounts receivable14.68
Inventories16.90
Prepaid Expense And Other Assets Current1.44
Total Current Assets94.07
Equipment/Property/Plant Net1.13
Deferred Costs, Noncurrent AS0.00
Other Assets, Noncurrent10.37
Restricted Cash Noncurrent0.12
Total Assets105.57
Liabilities
Accounts Payable, Current AC2.22
Accrued Liabilities, Current AC13.34
Other Liabilities, Current2.26
Taxes Payable0.00
Total Current Liabilities17.81
Long-term debt58.88
Total Long-term Debt58.88
Deferred Rent Credit, Noncurrent DE0.00
Accrued Income Taxes, Noncurrent0.00
Other liabilities, Noncurrent9.84
Operating Lease Liability Current2.12
Total Liabilities86.53
Stockholders' Equity
Common Stock Value0.03
Additional Paid In Capital Common Stock571.41
Retained Earnings / Accumulated Deficit-552.42
Other Equity0.00
Common Stockholder's Equity19.03
Total Stockholder's Equity19.03
Liabilities & Stockholder's Equity105.57
4 historic quarters locked

Sign in to unlock the full Neuropace Inc balance sheet history.

About Neuropace Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001528287-26-000011

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.